Adaptimmune Therapeutics PLC 10-K for FY2024
Adaptimmune Therapeutics PLC (ADAPY)
10-K
2025-03-24
For: 2024-12-31
View Original
Added on
June 11, 2026
About this 10-K
Adaptimmune Therapeutics PLC filed this 10-K on March 24, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $178.03M
- up 195.3% from $60.28M a year earlier
- Net loss
- $70.81M
- compared with a net loss of $113.87M a year earlier
- Diluted EPS
- -$0.05
- compared with -$0.09 a year earlier